QURE logo

QUREuniQure NV

$30.06
$0.18
(0.60%)
Pre-Market
Updated: 08:16 AM EDT·Prev Close $29.88
Reported EarningsMay 5
Mkt Cap$1.87B
Vol25,811.00
58

Bullish Sentiment

How do you feel about QURE?

News
all
press releases
Considering Uniqure NV (QURE) Stock? Read the AMT-130 Message
Considering Uniqure NV (QURE) Stock? Read the AMT-130 Message...
Yahoo! Finance: News
News Placeholder
More News
News Placeholder
REPL, QURE Stocks Rise Amid Makary’s Reported Resignation As FDA Chief
The New York Times reported that Makary’s departure was driven in large part by his strong opposition to the administration’s decision to authorize fruit-flavored e-cigarettes.
Stocktwits
News Placeholder
REPL, QURE, MRNA Soar On Reports Trump Will Fire FDA’s Marty Makary
The Wall Street Journal reported on the plans on Friday, citing people familiar with the matter, while noting that other top administration officials believe Makary is struggling to manage his agency.
Stocktwits
News Placeholder
uniQure Q1 Earnings Call Highlights
uniQure (NASDAQ:QURE) executives outlined progress and upcoming regulatory milestones for lead Huntington's disease gene therapy candidate AMT-130 during the company's first-quarter 2026 earnings call, while also providing updates across its epilepsy and Fabry programs and reviewing quarterly financ...
MarketBeat
News Placeholder
uniQure (NASDAQ:QURE) Issues Quarterly Earnings Results
uniQure (NASDAQ:QURE - Get Free Report) issued its quarterly earnings results on Tuesday. The biotechnology company reported ($0.85) EPS for the quarter, topping the consensus estimate of ($0.88) by $0.03. The company had revenue of $3.56 million during the quarter, compared to analysts...
MarketBeat
News Placeholder
uniQure (QURE) Reports Q1 Loss, Misses Revenue Estimates
uniQure (QURE) delivered earnings and revenue surprises of +2.86% and -48.75%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
uniQure (NASDAQ:QURE) Shares Up 6.3% - Still a Buy?
uniQure (NASDAQ:QURE) Stock Price Up 6.3% - Time to Buy...
MarketBeat
News Placeholder
Jennison Associates LLC Boosts Stake in uniQure N.V. $QURE
Jennison Associates LLC raised its position in shares of uniQure N.V. (NASDAQ:QURE - Free Report) by 37.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,371,190 shares of the biotechnology company's s...
MarketBeat
News Placeholder
uniQure (QURE) Projected to Post Earnings on Tuesday
uniQure (NASDAQ:QURE) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-5-uniqure-stock...
MarketBeat
News Placeholder
uniQure (NASDAQ:QURE) Given New $37.00 Price Target at Chardan Capital
Chardan Capital raised their price objective on uniQure from $31.00 to $37.00 and gave the stock a "buy" rating in a research report on Thursday...
MarketBeat
<
1
2
...
>